Randomized Trialmoderate evidence

Mechanical Thrombectomy Versus Anticoagulation Alone in Intermediate-High Risk PE: Improved Functional 90-Day Outcomes in STORM-PE RCT.

JACC. Cardiovascular interventions·October 26, 2026·PMID 42836810

Why it matters

Intermediate-high risk PE often leads to persistent functional limitations despite anticoagulation. This trial provides randomized evidence that mechanical thrombectomy can improve functional capacity and NYHA class at 90 days without increasing adverse events, informing reperfusion decisions in this population.

Infographic summary of Mechanical Thrombectomy Versus Anticoagulation Alone in Intermediate-High Risk PE: Improved Functional 90-Day Outcomes in STORM-PE RCT.
Visual abstract · MedLit

The papers that matter, first.

MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.

§

MedLit · Evidence, Distilled